ANI Pharmaceuticals (ANIP) director reports holding zero shares

Rhea-AI Filing Summary

ANI PHARMACEUTICALS INC (ANIP) filed an initial ownership report for Henry O. Gosebruch, who is identified as a director of the company. This Form 3 does not list any specific equity holdings or report any buy, sell, or derivative transactions in ANI common stock.

Key Terms

Form 3, initial statement of beneficial ownership, Power of Attorney

3 terms

Form 3 regulatory

"filed an initial ownership report for Henry O. Gosebruch"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

initial statement of beneficial ownership regulatory

"The filing is an initial statement of beneficial ownership"

An initial statement of beneficial ownership is the first regulatory filing an insider or large investor submits to disclose the amount of a company's stock they control or benefit from. It matters to investors because it reveals who has significant influence over a company—like showing who’s holding the cards—and helps track potential conflicts of interest, insider motives, and future buying or selling that can move the stock price.

Power of Attorney regulatory

"remarks note Exhibit 24 - Power of Attorney"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

What does this Form 3 filing mean for ANI PHARMACEUTICALS INC (ANIP)?

It reports that Henry O. Gosebruch is a director of ANI PHARMACEUTICALS INC. The filing is an initial statement of beneficial ownership and shows no reported transactions or specific share holdings at this time.

Did Henry O. Gosebruch buy or sell ANIP shares in this Form 3?

No. The Form 3 for Henry O. Gosebruch includes no reported transactions. The transaction summary shows zero buys, zero sells, and no derivative exercises or gifts.

Does the Form 3 disclose how many ANIP shares Henry O. Gosebruch owns?

No specific share holdings are listed. The structured data show no holding entries and zero shares associated with buys, sells, exercises, or gifts in this initial filing.

What role does Henry O. Gosebruch have at ANI PHARMACEUTICALS INC (ANIP)?

Henry O. Gosebruch is identified as a director of ANI PHARMACEUTICALS INC. He is not reported as an officer or a ten percent owner in this Form 3.

Is there any Rule 10b5-1 trading plan disclosed for ANIP in this Form 3?

No. The document-level 10b5-1 indicator is null, and the filing’s data and footnotes do not state that any trades occurred under a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/27/2026 - 04:21 PM Accepted by SEC EDGAR 08/27/2026 - 04:20 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Gosebruch Henry O

(Last) (First) (Middle)

C/O ANI PHARMACEUTICALS, INC.

104 CARNEGIE CENTER, SUITE 300

(Street)

PRINCETON NEW JERSEY 08540

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
08/19/2026

3. Issuer Name and Ticker or Trading Symbol
ANI PHARMACEUTICALS INC [ ANIP ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Henry O. Gosebruch, by attorney-in-fact Meredith W. Cook	08/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)